Pharmacopsychiatry是一本备受推崇的期刊,它为作者提供了一个分享药理学和精神病学交叉领域研究成果的平台。通过严格的同行评审程序,致力于发表高质量的科学研究,本刊为作者提供了在学术界获得认可和知名度的机会。
通过在Pharmacopsychiatry上发表论文,作者可以为推动药理精神病学的发展、影响临床实践以及改善全球精神卫生保健做出贡献。
Highlight Article
Share your work with a larger audience
Original Paper
High Prescribing and State-Level Variation in Z-Drug Use Among Medicare Patients
Anderson KE et al.
Z-drugs are nonbenzodiazepine hypnotics used for sleep initiation and maintenance; these drugs increase the risk of fall-related injuries in older adults. The American Geriatrics Society’s Beers criteria classifies Z-drugs as high-risk and strongly recommends avoiding prescribing Z-drugs to older adults due to adverse effects. The study objectives were to determine the prevalence of Z-drug prescribing among Medicare Part D patients and identify state or specialty-dependent prescribing differences. This study also aimed to determine prescribing patterns of Z-drugs to Medicare patients.